DEXA can also be used to assess central adiposity. DEXA measures of total abdominal fat correspond very well to measures of total abdominal fat by CT (11, 12). However, DEXA is unable to distinguish subcutaneous fat from intra-abdominal fat as it can only assess body composition two-dimensionally. As such, the association between DEXA measures of abdominal fat and CT or MRI measures of intra-abdominal fat tends to be much weaker than for total abdominal fat (11-14). Some have argued that the association between intra-abdominal fat and DEXA-measured abdominal fat is no better than that observed with simple tools such as waist circumference (11, 12, 15) and sagittal diameter (11, 12, 14). Further, DEXA can give rise to a phenomenon known as “beam hardening,” which may cause the true fat content of individuals with a large sagittal diameter (i.e., some obese individuals) to be underestimated (5, 9). Adiposity is more likely to be underestimated in the trunk than in the extremities, which have a smaller sagittal diameter.
DEXA is a useful tool for assessing total and abdominal obesity. However, DEXA is unable to break down abdominal fat into its subcutaneous and intra-abdominal fat components. In terms of accuracy, DEXA estimates of intra-abdominal fat are similar to those obtained by anthropometric measures such as waist circumference.

Role of the Dysregulated Endocannabinoid System in Determining Cardiometabolic Risk by Vincenzo Di Marzo, PhD
More
What is the role of low HDL cholesterol in the elevated CHD risk of metabolic syndrome patients? By Philip J. Barter, MBBS, FRACP, PhD
More
Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 2008;32:283-91
More
Schematic representation of how smoking might add to several mechanisms linking obesity to cardiovascular disease
More